SDIC Venture Capital Management, a subsidiary of State Development & Investment Corp (SDIC), has led a new funding round worth up to RMB507 million (US$76 million) in Zensun (Shanghai) Sci & Tech Co., Ltd., a biopharmaceutical company listed on the ChiNext board in Shenzhen.
SDIC Fund Management Company Ltd., a private equity firm majority owned by China’s State Development & Investment Corporation (SDIC), as well as an investment arm under China Life Insurance Co., Ltd., have led a RMB3.3 billion (US$500 million) series A round in Shanghai United Imaging Healthcare, a medical imaging equipment developer.
SDIC Chuangye Investment Management, a subsidiary of State Development & Investment Corp, has led a US$100 million series A round in Cambricon Technologies Co., Ltd., an artificial intelligence chip developer.
SkyGuard, a Beijing-based Internet security technology company, has raised a RMB150 million (US$24 million) series A round from 360 Enterprise Security Group, China Growth Capital and Guotou Chuangye, a venture capital unit of the State Development & Investment Corp (SDIC).
Novogene Corporation, a Chinese genomics and bioinformatics firm backed by CMB International Capital Management and the State Development & Investment Corporation (SDIC), has jointly established a whole genome sequencing center in Singapore by partnering with two institutions in the city-state.
China Merchants Bank’s CMB International Capital Management, a unit of State Development & Investment Corporation (SDIC) and Sigma Square Capital have invested RMB515 million (US$75 million) in a series B funding round in Beijing-based Novogene Technology, a commercial genomic services provider.